Background: Moyamoya disease (MM) is a rare disorder of the cerebral arterial circulation, whereas multiple sclerosis (MS) is a relatively common immune-mediated attack on central myelin. Despite the differences in pathogenesis, the 2 disorders share some clinical features which can lead to diagnostic confusion: both can affect young adults, cause intermittent neurological symptoms, and show multifocal abnormalities on brain imaging.
M ultiple sclerosis (MS) is a demyelinating disorder whose etiology and pathogenesis are incompletely understood, 1 and there exists no suitable biomarker for this disease. The diagnosis of MS continues to rely on criteria-prominent among which is the clinical and/or radiologic demonstration of multiple white-matter lesions in the central nervous system, disseminated both in space and in time. 2 The differential diagnosis of MS includes other disorders that can satisfy this central criterion, 3 but the prevalence of MS in North American and European populations is much higher (on the order of 1:1000) than that of most alternative diagnostic considerations, 4 so the young adult who presents with episodic neurological dysfunction-particularly if female-is often assumed to be suffering from MS until proved otherwise.
We call attention here to moyamoya disease (MM) in the differential diagnosis of MS in adults. MM is a progressive cerebral arteriopathy of uncertain etiology and pathogenesis, which often produces intermittent neurological symptoms and radiologic abnormalities, usually on the basis of cerebral ischemia. 5 Originally described mainly as a disorder of children in Asian populations, MM has been observed with increasing frequency among adults in other populations, 6 and is estimated to have an incidence on the order of 1:1,000,000 in North America. 7 In part because of its rarity, even a recent comprehensive review of differential diagnosis in MS fails to mention MM as a consideration. 8 Unlike MS, there may be a definitive treatment for MM, namely, surgical cerebral revascularization. 9 It is therefore imperative that the diagnosis of MM be made at the earliest possible stage of the illness, before the development of irreversible cerebral ischemic injury. We have observed 2 patterns of diagnostic confusion that have delayed the correct diagnosis and initiation of treatment in MM: (1) More commonly, MM was initially misdiagnosed as MS; (2) Less often, MM diagnosis was delayed because of coexisting MS. We describe examples of each, and review the clinical and radiologic features that may permit differentiation of these conditions early in the course.
METHODS
We retrospectively reviewed case histories from a large series of adults with MM who were treated at our institution, 9 to identify those in whom an initial diagnosis of MS had been made. The clinical findings in these patients were reviewed, and the radiologic imaging studies were analyzed with particular attention to the earliest available routine brain magnetic resonance (MR) imaging examination. This study was approved by the Stanford Administrative Panel on Human Subjects in Medical Research.
DETAILED CASE REPORTS

Case 1
A 42-year-old previously healthy woman began to experience intermittent numbness of her left arm and right leg in June 2003, and headaches and occasional brief episodes of diplopia. She had been depressed over the recent death of her mother, and the neurological symptoms caused her to become anxious and to experience palpitations and panic attacks. MR imaging showed several small foci of increased T2 signal mainly in the right centrum semiovale, with no evidence of restricted diffusion; the right middle cerebral artery (MCA) was noted to be small but patent. There was concern for several possible etiologies, including ischemia, demyelination, and metastatic disease. A search for a primary neoplasm was unrevealing. The cerebrospinal fluid (CSF) contained 28 red blood cells, 4 white blood cells with benign cytology, protein 35 mg/dL, glucose 55 mg/dL, IgG 4.3 mg/dL, and no oligoclonal bands. Tests for lyme disease, syphilis, HIV, and systemic inflammatory and autoimmune disorders were all negative. Brain biopsy from the right frontal lobe showed findings interpreted as consistent with demyelination, leading to a working diagnosis of MS versus acute disseminated encephalomyelitis.
She continued to have intermittent symptoms including episodes of left-sided shaking, right arm weakness, urinary frequency, forgetfulness, and migraine-like headaches. These were managed symptomatically. The neurological examination was entirely normal on multiple occasions. Because of increasing headache frequency and severity, brain MR imaging was repeated in May 2007. This showed an increased number of T2 hyperintensities now involving both centra semiovale, consistent with ischemic injuries, but again without restricted diffusion; and findings indicative of complete occlusion of the supraclinoid internal carotid arteries bilaterally. Catheter angiography confirmed the internal carotid artery occlusions, and demonstrated prominent moyamoya collateralization which, together with robust posterior circulation and large posterior communicating arteries, reconstituted the distal middle and anterior cerebral artery territories.
In July 2007 she underwent bilateral anastomoses of the superficial temporal artery (STA) to the MCA in 2 separate surgical procedures 1 week apart. After the left-sided procedure she manifested a transient aphasia which cleared spontaneously, and there was no MR evidence of infarct. Headaches and other symptoms ceased after surgery, except for infrequent brief paresthesias which persist. She is fully functional with normal neurological examination and stable MR findings, has returned to work, and is maintained on aspirin 81 mg daily.
Comment
Correct diagnosis and definitive treatment were delayed 4 years in this case. Fortunately, she did not experience a major stroke during this period. In the initial MR study, the early-stage disease in the right MCA could be appreciated even on the routine axial T2 images, and was in fact duly noted, but its significance was not fully appreciated. The brain biopsy tissue was subsequently re-reviewed and found to be compatible with ischemic injury.
Case 2
During her first pregnancy, in 1991, a 26-year-old ambidextrous woman experienced brief migratory paresthesias in both legs, and these continued to bother her thereafter. The following year she had recurrent episodes, lasting minutes, of left facial numbness and drooping. The neurological examination was normal, and the CSF showed no evidence of immune activation. An MR imaging study of the brain was unremarkable. She began to have bouts of fatigue, and momentary sensations of imbalance. In 1994 she abruptly developed severe leftsided weakness which rapidly evolved into a pure motor quadriparesis sparing sensation, sphincter functions, and cognition. Brain MR images were interpreted as showing findings consistent with diffuse inflammation. She was treated with corticosteroids followed by a 1.5-year course of first inpatient and then outpatient rehabilitation therapy, and made a gradual recovery, but was left with a moderate left hemiparesis affecting mainly the arm.
Over the next 15 years she continued to have bouts of fatigue and brief episodes of neurological dysfunction, including paresthesias, migratory numbness, and 1 episode of transient dysphasia. Electroencephalogram showed no evidence of epileptic activity. Serial brain and spine MR imaging studies showed no new active lesions. She was followed in the MS Clinic at a major academic medical center, and was advised that she had an "MS-like" illness. She had several courses of corticosteroid therapy with equivocal benefit, but immunomodulatory therapy was never recommended.
In 2010 she began to experience episodic weakness on her (stronger) right side, which prompted reevaluation. It was noted on repeat brain MR imaging that the left internal carotid artery appeared narrow. Magnetic resonance angiography and catheter angiography confirmed complete occlusion of both internal carotid arteries and both MCAs, with extensive moyamoya collateralization. She was treated with 2-stage STA-MCA bypass surgery, and had stormy postoperative courses complicated by seizures and fluctuating aphasia. She eventually recovered back to baseline, and returned to work full time, but continues to experience infrequent numb sensations on her right side, and brief episodes of dysphasia.
Comment
The diagnosis of MM was delayed 19 years in this case, the longest in our series. The treating subspecialists recognized that this was not a typical case of MS, and therefore did not recommend standard therapy, but apparently MM was never a serious differential diagnostic consideration.
Case 3
In 2006, a 44-year-old woman experienced 3 brief episodes of left hemiparesis affecting leg more than arm, each lasting a few minutes. Imaging of the spine and electromyographic testing were unrevealing. Neurological and neurosurgical consultants discussed the possibility of MS, but additional studies were not pursued, and a definite diagnosis was not forthcoming. She was asymptomatic thereafter for 3 years, then subacutely developed a left hemiparesis which persisted for months before improving. Repeat imaging, this time including both spine and brain, led to a diagnosis of MS, confirmed by the presence of oligoclonal bands in the CSF. She was treated with b-interferon-1a subcutaneously for 1 year, during which time she had no further symptoms. However, repeat brain imaging showed progression of abnormalities, so she was switched to glatiramer acetate, which she tolerated poorly. Several months later, in 2011, she abruptly again developed left hemiparesis, this time quite severe and affecting arm more than leg. This was initially treated as an MS exacerbation, with intravenous corticosteroids, until repeat brain imaging showed a large left frontal-central infarct. Additional investigations led to a diagnosis of MM, with complete occlusion of the left internal carotid artery, severe stenosis of the right internal carotid artery, and typical moyamoya collaterals bilaterally. In April 2011 she underwent 2-stage bilateral STA-MCA bypass surgery, which she tolerated well, but she has a fixed left hemiparesis including a largely nonfunctional left arm.
Comment
Considering the imaging findings and CSF abnormalities, this woman is thought most likely to suffer from both MS and MM, 1 of only 2 such patients in our series. It is not possible to specify the onset of either, but in retrospect the earliest symptoms were more suggestive of transient ischemic attacks than of MS attacks, which might indicate a delay in diagnosis of almost 5 years. Regrettably, she has been left with what will probably be permanent neurological impairment.
RESULTS
The clinical and radiologic features of the 11 patients, as derived from chart review, are summarized in Table 1 . The patients ranged in age from 15 to 42 years at symptom onset, and 10 were female. All experienced transient neurological symptoms of one kind or another at onset, and headache was present in 7. The initial diagnosis was MS in 9, and MS versus acute disseminated encephalomyelitis in 2. Five received active treatment for their MS diagnosis, including b-interferon, glatiramer acetate, and corticosteroids. The delay from symptom onset to MM diagnosis ranged from 2 months to 19 years, with a mean and median delay both equal to 4 years. Five have been left with ongoing neurological symptoms and/or disability that might arguably have been preventable.
For each patient, we reviewed the earliest available routine MR scan, and 10 specific findings were scored as present or absent. All scans included standard fast spin-echo T1weighted and T2-weighted images, GRE, fluid-attenuated inversion recovery (FLAIR) and diffusion sequences, and most also included postcontrast T1-weighted images. The assessed findings were: (1) the presence of abnormal collateral vessels traversing the basal ganglia; (2) diminished size of the intracranial carotid artery flow-voids and/or presence of vascular collaterals at the base of the brain (Fig. 1); (3) the presence of T2/FLAIR hyperintense lesions in the periventricular white matter, (4) in the watershed regions of the brain, (5) in the peripheral white matter, or (6) in the cerebral cortex; (7) the presence of the "ivy sign" on FLAIR images 10 ( Fig. 2A) ; (8) any diffusion-restricting lesions; (9) any enhancing lesions after gadolinium administration; and (10) the presence of the "ivy sign" on postgadolinium images (Fig. 2B) .
The results of the MR analyses are presented in Table 2 . All patients demonstrated abnormal flow-voids at the base of the brain on axial T2-weighted images. Many also demonstrated multifocal lesions in the subcortical white matter, but these generally spared the periventricular areas. Diffusionrestricting and contrast-enhancing lesions were uncommon.
DISCUSSION
Although MM and MS are both characterized by intermittent neurological symptoms, particularly early in the course, they can nevertheless usually be distinguished clinically by the timing of the episodes and by the presumptive localization of the neurological dysfunction. Transient ischemic events in MM characteristically are of paroxysmal onset, and typically resolve within 24 hours; whereas MS attacks (relapses, exacerbations) tend to evolve subacutely over days, and to resolve over days-to-weeks. 11 Because MM preferentially affects the anterior circulation, its symptoms generally reflect dysfunction of the cerebral hemispheres, in the territory of the anterior or MCAs. In contrast, episodes of demyelination in MS may involve white matter anywhere in the central nervous system, including brainstem, cerebellum, optic nerve, and spinal cord. Specific findings on neurological examination-such as internuclear ophthalmoparesis, optic atrophy, and spinal sensory or reflex levels-can help to confirm that the localization of dysfunction lies outside the region of vulnerability in MM.
Headache is not a common symptom in MS, though of course a headache disorder such as migraine may exist as a comorbidity. 12 Headache is more common in MM, 13 and was an early symptom in more than half of our patients. The 
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The Neurologist Volume 18, Number 6, November 2012 headaches in our patients resolved promptly after revascularization surgery, as is often the case, suggesting that in MM the headache is directly related to the vascular disease process. Static brain MR imaging studies can show patches of T2 hyperintensity in the subcortical cerebral white matter in both disorders, but it is informative to consider how these differ in the 2 diseases. In MM the abnormalities tend to be concentrated in the frontal and parietal watershed regions, may involve the deep or superficial grey matter, and-depending on the timing-may demonstrate ischemic features such as diffusion-positivity. 14 In MS the abnormalities show a predilection for the periventricular regions, especially the frontal horns and trigones of the lateral ventricles, and frequently involve the corpus callosum with radially oriented ovoid lesions sometimes referred to as "Dawson's fingers." MS lesions generally do not involve grey matter, at least on conventional MR images, but may show a distinctive pattern of juxtacortical localization, and may be found in brainstem, cerebellum, and other areas not typical for MM. 15 The key to the diagnosis of MM is imaging of the intracranial vasculature. In contemporary practice this usually begins with magnetic resonance angiography, which is sufficiently sensitive to detect the vascular pathology; followed by selective catheter arteriography to demonstrate the arterial narrowings and/or occlusions, the characteristic pattern of collateral circulation, and the availability of extracranial vessels for potential revascularization. Several types of cerebral blood flow studies are also under active investigation as adjunctive procedures. 16 However, even routine MR imaging is often sufficient for detection of vascular pathology, as in Case 1, above, where an abnormality of the MCA was noted early in the course, but the significance not fully appreciated. As MR imaging is generally performed in patients suspected of having MS, awareness of findings that can help to discriminate MS from a vascular pathology such as MM should be helpful to the treating clinician and the diagnostic radiologist (Table 3 ). In our series, all patients demonstrated abnormal flow-voids at the base of the brain on standard T2-weighted images (Fig. 1B) , though in most cases these abnormal flowvoids were not appreciated by the interpreting radiologists. Fast spin-echo T2-weighted images are routinely acquired as part of most brain imaging protocols done for a variety of symptoms and signs, and do not require any specialized hardware or software to perform and analyze. Assessing the flow-voids on every MR scan should be part of the radiologist's search pattern, and can help avoid misdiagnosis of these patients. Additional findings such as the "ivy sign" on FLAIR or postgadolinium images (Fig. 2) can be helpful, but each of these was present in less than half of our patient population.
In summary, we call attention to the fact that the early symptoms and imaging findings in MM can be mistaken for MS, leading to delay in diagnosis and treatment. Better awareness of MM as a differential diagnostic consideration, and careful analysis of the clinical and radiologic features of each case, will help to minimize misdiagnosis and treatment delay.
